Intelligent clinical trials on AWS: automating the trial operating model

Clinical trials are at a turning point. Despite advances in data standards and digital tools, many clinical development processes remain document driven. Protocols are authored in static formats, translated manually into downstream systems, and reconciled across functional teams. That often results in slow study start-up, duplicated effort across fragmented workflows, and operational surprises that inflate cost and timelines. Each translation step introduces delay and risk. Incremental automation of individual steps does not solve the core issue. As long as the protocol remains a static document, clinical development remains document led.

Our Intelligent Clinical Trials on AWS can change that equation. By transforming key trial elements into structured, machine-readable data, sponsors can move from document-led execution to a data-centric operating model. When combined with agentic AI, this foundation enables intelligent workflow orchestration across protocol authoring, budgeting, contracting, and study build.

Built on AWS, Intelligent Clinical Trials leverages scalable cloud infrastructure and advanced AI services to help sponsors accelerate trial execution while improving control and predictability.

Our Intelligent Clinical Trials redefines protocol as structured data, rather than static text. Key trial elements—endpoints, schedule of activities, eligibility criteria, schema, visit windows, and country or site selections—are defined in a unified, standardized data model. This enables three critical shifts:

• A unified trial data layer: A single source of truth captures core study elements in a structured format that downstream systems can directly consume.
• Modular, reusable components: Protocol elements become version-controlled building blocks that can be reused, benchmarked, and updated without rebuilding entire documents.
• Bi-directional design-to-execution flow: Changes in trial design propagate automatically into dependent systems—and operational insights can inform future design decisions.

With this foundation, the trial becomes executable. Study build artifacts, vendor specifications, and operational configurations can be generated directly from structured data rather than manually recreated.

When structured data anchors the trial, a new operating model becomes possible—one focused on orchestration rather than document translation. Examples include:

• Automated generation of study, country, and site budgets
• Direct configuration of electronic data capture (EDC) and related systems from structured schedules of activities
• Auto-generation of vendor specifications
• Dynamic updates when protocol amendments occur
• Real-time feasibility and complexity checks during design

Instead of rebuilding trial elements across multiple tools, sponsors can automate repetitive workflows and reduce reconciliation effort. This helps shorten study start-up, reduces rework, and improves predictability. More importantly, it can create the foundation for intelligent automation at scale.

Structured data enables automation. Agentic AI enables orchestration.

AI agents can reason over trial data, interact with systems, and coordinate multi-step workflows. In a document-centric environment, many of these workflows are executed manually and siloed across functions. Agents help connect and execute them intelligently.

Within an Intelligent Clinical Trials environment, agents can:

• Generate draft protocol sections from structured endpoints and schedules
• Produce vendor specifications and lab requirements based on trial design
• Draft study, country, and site budgets using structured visit and procedure data
• Support contract drafting and redline adjudication
•  Synchronize updates between the protocol document and structured trial data

Rather than automating isolated tasks, agents enable end-to-end workflow coordination. For example, a change to visit frequency in the Intelligent Clinical Trials can trigger:

• Regeneration of impacted protocol sections
• Updates to budget assumptions
• Adjustments to vendor specifications
• Notifications to downstream systems

This level of orchestration previously required coordination across medical writing, clinical operations, finance, and vendor management teams. Agentic workflows can reduce cognitive burden on these teams while preserving human oversight. Clinical professionals remain accountable for decisions, but repetitive generation, cross-referencing, and synchronization tasks can be automated. The result isn’t simply faster document production—it’s a shift toward intelligent, connected processes across the clinical development lifecycle.

Intelligent Clinical Trials is architected on AWS to provide the scalability and resilience needed for enterprise-scale clinical operations. Key capabilities include:

• Scalable compute and storage for structured trial data
• Secure data services supporting regulated environments
• AI and foundational model access through Amazon Bedrock
• Machine learning and embedded workflows via Amazon SageMaker
• Strong data integration and analytics services

AWS enables sponsors to deploy Intelligent Clinical Trials with security, compliance controls, and global scalability. At the same time, access to advanced AI services help accelerate innovation in agent-driven automation and workflow intelligence. This cloud-native architecture allows organizations to evolve capabilities over time without rebuilding infrastructure.

Implementing Intelligent Clinical Trials and agent-enabled workflows can realize measurable impacts, like:

• Reduced study start-up timelines through automation of study build and budgeting
• Lower manual effort across clinical operations and contracting teams
• Fewer reconciliation cycles during amendments
• Improved operational predictability through earlier visibility into design feasibility

Beyond efficiency, the strategic advantage lies in adaptability. Structured data and intelligent workflows allow organizations to respond more quickly to protocol changes, regulatory feedback, and operational signals.

The convergence of structured trial data, cloud platforms, and agentic AI is redefining how trials are designed and executed. By moving from static documents to actionable data, and from siloed tasks to orchestrated workflows, sponsors can:

• Connect trial design directly to execution
• Automate high-friction operational processes
• Enable intelligent, cross-functional coordination
• Scale securely on enterprise cloud infrastructure

Intelligent Clinical Trials isn’t just a new solution. It's the foundation for an automated clinical trial operating model—one designed for speed, intelligence, and continuous improvement.

As clinical development grows more complex, sponsors that lead with structured data and orchestrated AI workflows will likely be better positioned to deliver faster, more efficient trials and better patient outcomes.